The Phase 2b/3 trial is for 390 patients, double b
Post# of 148147
Quote:
The Phase 2b/3 trial is for 390 patients, double blinded with 2:1 ratio (active drug to placebo ratio).
https://www.cytodyn.com/newsroom/press-releas...-2b3-trial
Quote:
The Phase 2b/3 trial is for 390 patients, double blinded with 2:1 ratio (active drug to placebo ratio).